Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track JSPR with free AI briefings, catalyst countdowns, and dilution alerts.

JSPR · Jasper Therapeutics, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$7.3M Cash on Hand

2mo Cash Runway

Follow JSPR by email Get an email when JSPR pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about JSPR, unsubscribe in one click. Privacy

🧪 Trial & FDA Catalysts

Dec 2026 · N/A · Recruiting · CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
Registry primary completion date, not a results date
Jan 2027 · N/A · Recruiting · The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (
Registry primary completion date, not a results date
Jan 2027 · N/A · Recruiting · The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma
Registry primary completion date, not a results date
Jan 2028 · N/A · Recruiting · The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 220
Registry primary completion date, not a results date
Jan 2028 · N/A · Recruiting · The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Registry primary completion date, not a results date
Mar 2029 · Phase 3 · Recruiting · Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
Registry primary completion date, not a results date

📊 Drug Pipeline

Drug	Indication	Most advanced trial	Status
Nelfinavir	Healthy Volunteers	Phase 4 · NCT00251030	Completed
Briquilimab (JSP191)	Chronic Spontaneous Urticaria	Phase 1/2 · NCT06162728	Completed
Cycloserine	Social Anxiety Disorder	Early Phase 1 · NCT02066792	Completed

Also used in these trials (approved or third-party drugs, not JSPR's own candidates): Nicotine, Isradipine, Lomustine, Temozolomide.

Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it

💰 Cash Runway & Dilution Risk

JSPR holds $7.3M in cash and short-term investments (as of Jun 30, 2026) and burns about $10.7M/quarter from operations, an estimated runway of 2 months at that rate (BioRadar estimate, not company guidance).

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when JSPR files for a raise →

Get the full JSPR picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for JSPR and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z